DongKoo Bio & Pharma Co., Ltd. (KOSDAQ:006620)
South Korea flag South Korea · Delayed Price · Currency is KRW
5,170.00
-80.00 (-1.52%)
At close: Apr 28, 2026

DongKoo Bio & Pharma Balance Sheet

Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year
FY 2025 FY 2024 FY 2023 FY 2022 FY 2021 2020 - 2017
Period Ending
Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 2020 - 2017
Cash & Equivalents
21,56125,37215,71312,51419,557
Upgrade
Short-Term Investments
1,107506.91,9411,351143.14
Upgrade
Trading Asset Securities
12,49710,3715,24521,27112,399
Upgrade
Cash & Short-Term Investments
35,16536,25022,89835,13632,100
Upgrade
Cash Growth
-3.00%58.31%-34.83%9.46%8.50%
Upgrade
Accounts Receivable
19,34319,87619,87918,50315,774
Upgrade
Other Receivables
253.081,3521,570898.47633.49
Upgrade
Receivables
21,37023,95322,44919,40216,408
Upgrade
Inventory
49,99645,96242,60631,42824,964
Upgrade
Prepaid Expenses
450.63324.71216.61225.89229.66
Upgrade
Other Current Assets
19,320751.62195.021,226131.5
Upgrade
Total Current Assets
126,301107,24288,36587,41773,832
Upgrade
Property, Plant & Equipment
77,44566,22250,48339,68140,051
Upgrade
Long-Term Investments
121,47650,41939,80033,61935,498
Upgrade
Other Intangible Assets
5,3865,46710,9039,0103,048
Upgrade
Long-Term Deferred Tax Assets
-3,162291.56.95-
Upgrade
Long-Term Deferred Charges
2,9377,705---
Upgrade
Other Long-Term Assets
2,8053,8431,2602,3252,358
Upgrade
Total Assets
336,350244,061191,103172,059154,786
Upgrade
Accounts Payable
5,29115,59111,20214,30011,591
Upgrade
Accrued Expenses
9,92011,33710,2749,6376,496
Upgrade
Short-Term Debt
105,15674,87640,50033,00018,070
Upgrade
Current Portion of Long-Term Debt
----5,000
Upgrade
Current Portion of Leases
639.78681.03842.63567.83453.23
Upgrade
Current Income Taxes Payable
390.963,3251,6382,5761,978
Upgrade
Other Current Liabilities
16,0769,4418,8635,9636,434
Upgrade
Total Current Liabilities
137,473115,25173,31866,04450,022
Upgrade
Long-Term Debt
22,85210,4671,447--
Upgrade
Long-Term Leases
134.07616.951,014754.22770.27
Upgrade
Pension & Post-Retirement Benefits
00277.090205.81
Upgrade
Long-Term Deferred Tax Liabilities
6,7778.894.5140.932,315
Upgrade
Other Long-Term Liabilities
16,95412,2694,5963,0151,350
Upgrade
Total Liabilities
184,190138,61380,65869,95354,662
Upgrade
Common Stock
14,23214,23214,23214,23214,232
Upgrade
Additional Paid-In Capital
33,55533,06333,06333,06333,063
Upgrade
Retained Earnings
114,06167,32069,73561,67557,158
Upgrade
Treasury Stock
-10,545-10,545-7,137-7,058-4,062
Upgrade
Comprehensive Income & Other
398.211,261507.18193.39-266.18
Upgrade
Total Common Equity
151,702105,332110,400102,106100,124
Upgrade
Minority Interest
456.9116.0344.92--
Upgrade
Shareholders' Equity
152,159105,448110,445102,106100,124
Upgrade
Total Liabilities & Equity
336,350244,061191,103172,059154,786
Upgrade
Total Debt
128,78286,64143,80434,32224,294
Upgrade
Net Cash (Debt)
-93,617-50,391-20,906813.887,806
Upgrade
Net Cash Growth
----89.57%33.61%
Upgrade
Net Cash Per Share
-3335.20-1856.67-756.8929.32276.23
Upgrade
Filing Date Shares Outstanding
27.0427.0427.6127.6228.04
Upgrade
Total Common Shares Outstanding
27.0427.0427.6127.6228.04
Upgrade
Working Capital
-11,173-8,00915,04621,37423,811
Upgrade
Book Value Per Share
5609.353895.103998.843696.333570.78
Upgrade
Tangible Book Value
146,31799,86599,49793,09697,076
Upgrade
Tangible Book Value Per Share
5410.213692.933603.923370.163462.08
Upgrade
Land
13,26213,26210,84910,84910,584
Upgrade
Buildings
28,81527,61329,66727,35326,899
Upgrade
Machinery
9,52012,45619,76817,74117,813
Upgrade
Construction In Progress
21,2837,82310,6941,451887.9
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.